AI assistant
OMNICELL, INC. — Director's Dealing 2019
Sep 30, 2019
31980_dirs_2019-09-30_bb004f9a-a1d3-4735-b291-3571c760a9a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2019-09-12
Reporting Person: Seidelmann Scott Peter (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-12 | Common Stock | M | 1300 | — | Acquired | 27633 | Direct |
| 2019-09-12 | Common Stock | S | 1300 | $75.1685 | Disposed | 26333 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-09-12 | Stock Options NQ (Right to Buy) | $43.30 | M | 1300 | Disposed | 2028-04-19 | Common Stock (1300) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 26333 | Direct |
Footnotes
F1: The price reported in Column 4 is the average price of $75.1685. The sold price range between $75.00 to $75.27. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.
F3: Due to an administrative error, this sale was originally reported as a sale of directly owned shares; this amendment is being filed to correctly reflect that the sale was pursuant to an exercise of options and subsequent sale of underlying shares.